High relapse rate in children with non-advanced nodular lymphocyte predominant Hodgkin's lymphoma (NLPHL or nodular paragranuloma) treated with chemotherapy only

Leukemia and Lymphoma

Volumn 47, Issue 8, 2006, Pages 1504-1510

  van Grotel, Martine ^a   Lam, King H ^b   de Man, Rogier ^a   Beishuizen, Auke ^a   Pieters, Rob ^a   van den Heuvel EiBrink, Marry M ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b JOSEPHINE NEFKENS INSTITUTE   (Netherlands)

Author keywords

Childhood; NLPHL; Nodular lymphocyte predominant Hodgkin's lymphoma

Indexed keywords

BLEOMYCIN; CARMUSTINE; CHLORMETHINE; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; DACARBAZINE; EPIRUBICIN; ETOPOSIDE; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE SULFATE;

ADOLESCENT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; IMMUNOHISTOCHEMISTRY; JAW DISEASE; MALE; NODULAR LYMPHOCYTE PREDOMINANT HODGKIN DISEASE; PRIORITY JOURNAL; THYROID DISEASE; TREATMENT OUTCOME;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CHILD; DACARBAZINE; EPIRUBICIN; FEMALE; FOLLOW-UP STUDIES; HODGKIN DISEASE; HUMANS; LYMPHOMA, B-CELL; MALE; RECURRENCE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SALVAGE THERAPY; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VINBLASTINE;

EID: 33748527181     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190600573291     Document Type: Article

References (36)

1. Lukes, R and Butler, J. (1966) The pathology and nomenclature of Hodgkin's disease Cancer Res, 26, pp. 1063-1083.
2. Harris, N and Jaffe, E and Stein, H and Banks, P and Chan, J and Cleary, M and (1994) A revised European - American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group Blood, 84, pp. 1361-1392.
3. Rudiger, T and Ott, G and Ott, M and Muller-Deubert, S and Muller-Hermelink, H. (1998) Differential diagnosis between classic Hodgkin's lymphoma, T-cell-rich B-cell lymphoma, and paragranuloma by paraffin immunohistochemistry Am J Surg Pathol, 22, pp. 1184-1191.
4. Uherova, P and Valdez, R and Ross, C and Schnitzer, B and Finn, W. (2003) Nodular lymphocyte predominant Hodgkin lymphoma. An immunophenotypic reappraisal based on a single-institution experience Am J Clin Pathol, 119, pp. 192-198.
5. Jaffe, E and Harris, N and Stein, H and Vardiman, J. (2001) World Health Organisation Classification of tumours: Pathology & genetics: Tumours of haematopoietic and lymphoid tissues. Lyon: IARC.
6. Landberg, T and Larsson, L. (1969) Hodgkin's disease. Retrospective clinico-pathologic study in 149 patients Acta Radiol Ther Phys Biol, 8, pp. 390-414.
7. Keller, A and Kaplan, H and Lukes, R and Rappaport, H. (1968) Correlation of histopathology with other prognostic indicators in Hodgkin's disease Cancer, 22, pp. 487-499.
8. Hansmann, M and Zwingers, T and Boske, A and Loffler, H and Lennert, K. (1984) Clinical features of nodular paragranuloma (Hodgkin's disease, lymphocyte predominance type, nodular) J Cancer Res Clin Oncol, 108, pp. 321-330.
9. Franklin, J and Tesch, H and Hansmann, M and Diehl, V. (1998) Lymphocyte predominant Hodgkin's disease: Pathology and clinical implication Ann Oncol, 9(Suppl 5), pp. S39-S44.
10. Hakvoort-Cammel, F and Buitendijk, S and van den Heuvel-Eibrink, M and Hahlen, K. (2004) Treatment of pediatric Hodgkin disease avoiding radiotherapy: Excellent outcome with the Rotterdam-HD-84-protocol Pediatr Blood Cancer, 43, pp. 8-16.
11. Poppema, S and Kaiserling, E and Lennert, K. (1979) Hodgkin's disease with lymphocytic predominance, nodular type (nodular paragranuloma) and progressively transformed germinal centres - A cytohistological study Histopathology, 3, pp. 295-308.
12. Anagnostopoulos, I and Hansmann, M and Franssila, K and Harris, M and Harris, N and Jaffe, E and (2000) European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: Histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes Blood, 96, pp. 1889-1899.
13. Nicholas, D and Harris, S and Wright, D. (1990) Lymphocyte predominance Hodgkin's disease - An immunohistochemical study Histopathology, 16, pp. 157-165.
14. von Wasielewski, R and Werner, M and Fischer, R and Hansmann, M and Hubner, K and Hasenclever, D and (1997) Lymphocyte-predominant Hodgkin's disease. An immunohistochemical analysis of 208 reviewed Hodgkin's disease cases from the German Hodgkin Study Group Am J Pathol, 150, pp. 793-803.
15. Tefferi, A and Zellers, R and Banks, P and Therneau, T and Colgan, J. (1990) Clinical correlates of distinct immunophenotypic and histologic subcategories of lymphocyte-predominance Hodgkin's disease J Clin Oncol, 8, pp. 1959-1965.
16. Sandoval, C and Venkateswaran, L and Billups, C and Slim, M and Jayabose, S and Hudson, M. (2002) Lymphocyte-predominant Hodgkin disease in children J Pediatr Hematol Oncol, 24, pp. 269-273.
17. Murphy, S and Morgan, E and Katzenstein, H and Kletzel, M. (2003) Results of little or no treatment for lymphocyte-predominant Hodgkin disease in children and adolescents J Pediatr Hematol Oncol, 25, pp. 684-687.
18. Karayalcin, G and Behm, F and Gieser, P and Kung, F and Weiner, M and Tebbi, C and (1997) Lymphocyte predominant Hodgkin disease: clinico-pathologic features and results of treatment - The Pediatric Oncology Group experience Med Pediatr Oncol, 29, pp. 519-525.
19. Hutchinson, R and Fryer, C and Davis, P and Nachman, J and Krailo, M and O'Brien, R and (1998) MOPP or radiation in addition to ABVD in the treatment of pathologically staged advanced Hodgkin's disease in children: Results of the Children's Cancer Group Phase III Trial J Clin Oncol, 16, pp. 897-906.
20. Nachman, J and Sposto, R and Herzog, P and Gilchrist, G and Wolden, S and Thomson, J and (2002) Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy J Clin Oncol, 20, pp. 3765-3771.
21. Pellegrino, B and Terrier-Lacombe, M and Oberlin, O and Leblanc, T and Perel, Y and Bertrand, Y and (2003) Lymphocyte-predominant Hodgkin's lymphoma in children: Therapeutic abstention after initial lymph node resection - A Study of the French Society of Pediatric Oncology J Clin Oncol, 21, pp. 2948-2952.
22. Delabie, J and Vandenberghe, E and Kennes, C and Verhoef, G and Foschini, M and Stul, M and (1992) Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype Am J Surg Pathol, 16, pp. 37-48.
23. Borg-Grech, A and Radford, J and Crowther, D and Swindell, R and Harris, M. (1989) A comparative study of the nodular and diffuse variants of lymphocyte-predominant Hodgkin's disease J Clin Oncol, 7, pp. 1303-1309.
24. Regula, D, Jr. and Hoppe, R and Weiss, L. (1988) Nodular and diffuse types of lymphocyte predominance Hodgkin's disease N Engl J Med, 318, pp. 214-219.
25. Meignin, V and Briere, J and Brice, P and Gisselbrecht, C and Gaulard, P and Janin, A. (2000) Hodgkin disease with nodular lymphocytic predominance or type I (paragranuloma of Poppema - Lennert): A clinico-pathological entity. Study of 21 cases and review of the literature Ann Pathol, 20, pp. 19-24.
26. Chul, S. (1999) Hodgkin's disease with lymphocyte predominance: Long-term results based on current histopathologic criter Int J Rad Oncol Biol Physics, 43, pp. 241-467.
27. Bhatia, S and Robison, L and Oberlin, O and Greenberg, M and Bunin, G and Fossati-Bellani, F and (1996) Breast cancer and other second neoplasms after childhood Hodgkin's disease N Engl J Med, 334, pp. 745-751.
28. van Leeuwen, F and Klokman, W and Veer, M and Hagenbeek, A and Krol, A and Vetter, U and (2000) Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood J Clin Oncol, 18, pp. 487-497.
29. Hudson, M and Krasin, M and Kaste, S. (2004) PET imaging in pediatric Hodgkin's lymphoma Pediatr Radiol, 34, pp. 190-198.
30. Rehwald, U and Schulz, H and Reiser, M and Sieber, M and Staak, J and Morschhauser, F and (2003) Treatment of relapsed CD20+ Hodgkin lymphoma with the monoclonal antibody rituximab is effective and well tolerated: results of a phase 2 trial of the German Hodgkin Lymphoma Study Group Blood, 101, pp. 420-424.
31. Keilholz, U and Szelenyi, H and Siehl, J and Foss, H and Knauf, W and Thiel, E. (1999) Rapid regression of chemotherapy refractory lymphocyte predominant Hodgkin's disease after administration of rituximab (anti CD 20 monoclonal antibody) and interleukin-2 Leuk Lymphoma, 35, pp. 641-642.
32. Ekstrand, B and Lucas, J and Horwitz, S and Fan, Z and Breslin, S and Hoppe, R and (2003) Rituximab in lymphocyte-predominant Hodgkin disease: results of a phase 2 trial Blood, 101, pp. 4285-4289.
33. Chan, W. (1999) Cellular origin of nodular lymphocyte-predominant Hodgkin's lymphoma: Immunophenotypic and molecular studies Semin Hematol, 36, pp. 242-252.
34. Boulanger, E and Meignin, V and Leverger, G and Solal-Celigny, P. (2003) Rituximab monotherapy in nodular lymphocyte-predominant Hodgkin's disease Ann Oncol, 14, pp. 171.
35. Diehl, V and Sextro, M and Franklin, J and Hansmann, M and Harris, N and Jaffe, E and (1999) Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: Report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease J Clin Oncol, 17, pp. 776-783.
36. Miettinen, M and Franssila, K and Saxen, E. (1983) Hodgkin's disease, lymphocytic predominance nodular. Increased risk for subsequent non-Hodgkin's lymphomas Cancer, 51, pp. 2293-2300.